Increased plasma incretin concentrations identifies a subset of patients with persistent congenital hyperinsulinism without KATP channel gene defects

Journal of Pediatrics

Volumn 166, Issue 1, 2015, Pages 191-194

  Shi, Yanqin ^a   Avatapalle, Hima B ^b   Skae, Mars S ^b   Padidela, Raja ^b   Newbould, Melanie ^b   Rigby, Lindsey ^b   Flanagan, Sarah E ^c   Ellard, Sian ^c   Rahier, Jacques ^d   Clayton, Peter E ^b,e   Dunne, Mark J ^a   Banerjee, Indraneel ^b   Cosgrove, Karen E ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^d CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

CHI Congenital hyperinsulinism; CHI A Atypical congenital hyperinsulinism; CHI D Diffuse congenital hyperinsulinism; CHI F Focal congenital hyperinsulinism; GIP Glucose dependent insulinotropic peptide; GLP 1 Glucagon like peptide 1

Indexed keywords

ADENOSINE TRIPHOSPHATE; BIOLOGICAL MARKER; DIAZOXIDE; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; HEXOKINASE 1; INCRETIN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; OCTREOTIDE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL;

ADOLESCENT; ARTICLE; ATYPICAL CONGENITAL HYPERINSULINISM; CHILD; CLINICAL ARTICLE; DIET RESTRICTION; DIFFUSE CONGENITAL HYPERINSULINISM; EXON; FOCAL CONGENITAL HYPERINSULINISM; GENE EXPRESSION; GENE MUTATION; HUMAN; HYPOGLYCEMIA; INFANT; INTRON; PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; POSTPRANDIAL STATE; PRESCHOOL CHILD; PRIORITY JOURNAL; TRANSIENT CONGENITAL HYPERINSULINISM; BLOOD; GENETICS; MUTATION; NEWBORN; UNITED KINGDOM;

BIOLOGICAL MARKERS; CHILD, PRESCHOOL; CONGENITAL HYPERINSULINISM; GREAT BRITAIN; HUMANS; INCRETINS; INFANT; INFANT, NEWBORN; KATP CHANNELS; MUTATION;

EID: 84922021098     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2014.09.019     Document Type: Article

References (16)

1. De León DD, Stanley CA. Mechanisms of disease: advances in diagnosis and treatment of hyperinsulinism in neonates. Nat Clin Pract Endocrinol Metab 2007;3:57-68.
2. Mohamed Z, Arya VB, Hussain K. Hyperinsulinaemic hypoglycaemia: genetic mechanisms, diagnosis and management. J Clin Res Pediatr Endocrinol 2012;4:169-81.
3. Avatapalle HB, Banerjee I, Shah S, Pryce M, Nicholson J, Rigby L, et al. Abnormal neurodevelopmental outcomes are common in children with transient congenital hyperinsulinism. Front Endocrinol 2013;4:60.
4. Banerjee I, Skae MS, Flanagan SE, Rigby L, Patel L, Didi M, et al. The contribution of rapid KATP channel gene mutation analysis to the clinical management of children with congenital hyperinsulinism. Eur J Endocrinol 2011;164:733-40.
5. Kapoor RR, Flanagan SE, Arya VB, Shield JP, Ellard S, Hussain K. Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism. Eur J Endocrinol 2013;168:557-64.
6. Snider KE, Becker S, Boyajian L, Shyng SL, MacMullen C, Hughes N, et al. Genotype and phenotype correlations in 417 children with congenital hyperinsulinism. J Clin Endocrinol Metab 2013;98:E355-63.
7. Sempoux C, Capito C, Bellanné-Chantelot C, Verkarre V, de Lonlay P, Aigrain Y, et al. Morphological mosaicism of the pancreatic islets: a novel anatomopathological form of persistent hyperinsulinemic hypoglycemia of infancy. J Clin Endocrinol Metab 2011;96:3785-93.
8. Campbell JE, Drucker DJ. Pharmacology, physiology, and mechanisms of incretin hormone action. Cell Metab 2013;17:819-37.
9. Banerjee I, Avatapalle HB, Padidela R, Stevens A, Cosgrove KE, Clayton PE, et al. Integrating genetic and imaging investigations into the clinical management of congenital hyperinsulinism. Clin Endocrinol 2013;78:803-13.
10. Flanagan SE, Xie W, Caswell R, Damhuis A, Vianey-Saban C, Akcay T, et al. Next-generation sequencing reveals deep intronic cryptic ABCC8 and HADH splicing founder mutations causing hyperinsulinism by pseudoexon activation. Am J Hum Genet 2013;92:131-6.
11. Henquin JC, Sempoux C, Marchandise J, Godecharles S, Guiot Y, Nenquin M, et al. Congenital hyperinsulinism caused by hexokinase I expression or glucokinase-activating mutation in a subset of β-cells. Diabetes 2012;62:1689-96.
12. Palladino AA, Sayed S, Levitt Katz LE, Gallagher PR, De León DD. Increased glucagon-like peptide-1 secretion and postprandial hypoglycemia in children after Nissen fundoplication. J Clin Endocrinol Metab 2009;94:39-44.
13. Myint KS, Greenfield JR, Farooqi IS, Henning E, Holst JJ, Finer N. Prolonged successful therapy for hyperinsulinaemic hypoglycaemia after gastric bypass: the pathophysiological role of GLP1 and its response to a somatostatin analogue. Eur J Endocrinol 2012;166:951-5.
14. Wang Y, Egan JM, Raygada M, Nadiv O, Roth J, Montrose-Rafizadeh C. Glucagon-like peptide-1 affects gene transcription and messenger ribonucleic acid stability of components of the insulin secretory system in RIN 1046-38 cells. Endocrinology 1995;136:4910-7.
15. Wang Y, Montrose-Rafizadeh C, Adams L, Raygada M, Nadiv O, Egan JM. GIP regulates glucose transporters, hexokinases, and glucose-induced insulin secretion in RIN 1046-38 cells. Mol Cell Endocrinol 1996;116:81-7.
16. + channel. Diabetes 2012;61:2585-91.